Navigation Links
Asmanex Twisthaler launched by Schering-Plough for treatment of asthma

Asmanex Twisthaler has been launched by Schering-Plough as therapy in the control and management of mild, moderate or severe persistent asthma in patients 12 years of age and older. It was launched in the United Kingdom in January and is expected to be launched in the other European Union(EU) markets, in the next few months. Asmanex Twisthaler, a dry powder inhaler, contains the orally// inhaled corticosteroid mometasone furoate, which was discovered and developed by Schering-Plough Research Institute. The product employs a state-of-the-art, inhalation-driven device that does not use a propellant, thus eliminating the need for hand-breath coordination.

Asmanex Twisthaler represents a major new treatment option in helping asthma patients manage their disease and is a valuable addition to the therapies available to physicians for treating asthma, which is a serious and life-threatening disease. Richard Jay Kogan, President and CEO of Schering-Plough said that Asmanex, which is the first asthma therapy in international markets, represents an important advance for Schering-Plough and will significantly strengthen its respiratory portfolio, which includes Nasonex, an inhaled nasal steroid for allergies, and Clarinex, the once-daily non-sedating antihistamine. The Chairman, Hans-Jorg Kummer, added that the product's proven efficacy, convenient once-daily dosing and easy-to-use device would help patients better adhere to their dosing regimen and assist in achieving control of their asthma symptoms.


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. New initiative launched to fight malaria by repelling mosquitoes
3. Clarithromycin tablets to be launched in India soon
4. Guide for physicians launched to help them identify alcohol disorders
5. New X-ray machine launched by GE Healthcare
6. Historic trial for tuberculosis launched together by leading drug companies
7. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
8. Hot Air Balloon Festival launched in Rajasthan
9. Thyroid hormone treatment hastens recovery after cardiac surgery
10. Feeding channel created by malaria parasite - a new target for malaria treatments
11. Now umbilical cord helps in stroke treatment.
Post Your Comments:
(Date:1/7/2009)... , (Baltimore) The Greenwall Foundation recently...kins Berman Institute of Bioethics a grant that wi... to explore the ethical challenges health professi...affected by life-threatening neuromuscular disease...udy grew out of the work of the international Hear...
(Date:1/7/2009)... , Rx-tra Savings is Available at Albertsons store...ISE, Idaho, Jan. 7 Albertson,s LLC announced an e...iption discount program today by introducing a new...0 generic drugs. In addition, Albertsons has adde... 500 drugs that are already covered by this discou...
(Date:1/7/2009)... , ALBANY, Ore., Jan. 7 Synthetech, Inc.,(OTC...Performance Improvement,Awards for their outstandi...ealth, Safety, & Security (EHS&S) Planning...The Silver Awards are presented by the Synthetic O...and sponsored by ChemStewards,SOCMA,s EHS&S im...
(Date:1/7/2009)... , OWINGS MILLS, Md., Jan. 7 Medifast, Inc. (NYSE...s program, today announced they,ve been named a Fu...edifast is a 2007 and 2009 winner of this award. ...st growing companies in the Greater Baltimore area...nounced on December 16, 2008 that The Company expe...
Breaking Medicine News(10 mins):Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 3Health News:Albertson's LLC Launches $10.99 for 90-day Supply of Generic Drugs as Part of Rx-tra Savings Prescription Discount Program 2Health News:Synthetech Earns National Recognition for Performance Improvement Program 2Health News:Synthetech Earns National Recognition for Performance Improvement Program 3Health News:Medifast Named Baltimore SmartCEO Future 50 Company for Second Time 2
...Spraying salty water (saline) into your nose can h...at accompany long-term infections of the nasal pas...rsistent infection of the nasal passages (chronic ...nd yogic forms of healthcare recommend spraying sa...
...tematic Review,there are no high quality data to a...tes work in people who have just been told they h... on exercise seems to be one way of improving bloo... a person at danger of having elevated levels of s...
... - a huge pink hot air balloon - is set Friday to ...areness . The balloon - which organisers hope will...oned by seven local branches of the public medical...tival in Lichtenvoorde, a small town near Almelo i...
...led a plan for coping with a pandemic flu outbreak...ty to detect a disease outbreak and track its prog...ecided that it will not close the borders if a pan...in the world. Says Dr. Rajeev Venkayya, special as...
Other Medicine News:Health News:Less Information on Dietary Treatment in Type2 Diabetes 2Health News:Americas Preparations For Flu Outbreak Still Incomplete 2
(Date:1/7/2009)...Tiantan Puhua Hospital Stem Cells Center ( http://...using stem cells to effectively treat neurological...ienced additions to its medical and research staff...t capabilities for growing numbers of incoming int...e the distinguished Dr. Jiang Ping, who was named ...
(Date:1/6/2009)...sults from prior U.S., U.K. and China Trials , ,...s, Inc. (VTI), a development stage company targeti...nt has begun for a randomized, controlled, multi-c...Extracorporeal Liver Assist Device (ELAD) as a tre... under three protocols. The study is open for enro...
(Date:1/6/2009)...e/ -- In recent controlled studies conducted by Dr...ists found that the patented ingredient in Glyc,n ... ingredient to increase levels of nitric oxide (NO...trate (NOx) in human subjects. , , Nitric oxide...blood flow to the skeletal muscles. This is signi...
(Date:1/6/2009)...re-USNewswire/ -- Sequella, Inc., a clinical-stage...epidemic potential, announced today that SQ109, it...losis (TB), was the first drug approved for evalua...to Dynport Vaccine Company LLC and Quintiles Trans...stitute of Allergy and Infectious Diseases (NIAID)...
Breaking Medicine Technology:Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 1Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 2Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 3Surviving the revolution easier than withstanding human use and abuse 4415 1Surviving the revolution easier than withstanding human use and abuse 4415 2Surviving the revolution easier than withstanding human use and abuse 4415 3USC researchers identify alternate pathway that leads to palate development 4411 1USC researchers identify alternate pathway that leads to palate development 4411 2USC researchers identify alternate pathway that leads to palate development 4411 3Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 1Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 3
...the CDC that none of its influenza vaccine (Fluvir...ted States for the current influenza season. In th...e anticipated American vaccine supply, medical off...gly alarmed about the scarcity of vaccine and the ...e seen if virulent new strains of flu or an abnorm...
...f rapid, easy-to-use diagnostic tests, many assays...ace to help clinicians assess dosage appropriatene...ence of drugs of abuse. Some of these products req...s are suitable for point of care use by medical pr..., Therapeutic drug monitoring measures the serum ...
Other Medicine Technology:Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 2Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 4
TowerPack is an innovative, quick and easy automated refill system for Diamond Tips. Use 60% less space on your laboratory bench and 70% less plastic. With this amazingly easy-to-use, one-hand system
With its wide orifice tip, the Finntip Wide is designed especially for pipetting fragile cell suspensions and macromolecules like genomic DNA. This tip eliminates the mechanical shearing that causes
200 L, Racked, Pre-sterilized, 96 tips/rack Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less.
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
Medicine Products: